M1381 Patients with secondary stroke (e.g., a subsequent stroke that may occur with vasospasm in the setting of subarachnoid hemorrhage) within 5 days of the initial procedure
Billable / valid for submission HCPCS Release 2026Q3
Short description: Pt sec strk wthin 5 days
Version history
| Release | Valid from | Valid to | Description | Billable |
|---|---|---|---|---|
| 2026Q3 | 2026-07-01 | current | Patients with secondary stroke (e.g., a subsequent stroke that may occur with vasospasm in the setting of subarachnoid hemorrhage) within 5 days of the initial procedure | yes |
Related codes in M13
- M1300 Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons)
- M1301 Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy)
- M1302 Screening, diagnostic, film digital or digital breast tomosynthesis (3d) mammography results documented and reviewed
- M1303 Hospice services provided to patient any time during the measurement period
- M1304 Patient did not receive any pneumococcal conjugate or polysaccharide vaccine on or after their 19th birthday and before the end of the measurement period
- M1305 Patient received any pneumococcal conjugate or polysaccharide vaccine on or after their 19th birthday and before the end of the measurement period
- M1306 Patient had anaphylaxis due to the pneumococcal vaccine any time during or before the measurement period
- M1307 Documentation stating the patient has received or is currently receiving palliative or hospice care
- M1308 Influenza immunization was not administered, reason not given
- M1309 Palliative care services provided to patient any time during the measurement period
- M1310 Patient screened for tobacco use and received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling, pharmacotherapy, or both), if identified as a tobacco user
- M1311 Anaphylaxis due to the vaccine on or before the date of the encounter
- M1312 Patient not screened for tobacco use
- M1313 Tobacco screening not performed or tobacco cessation intervention not provided during the measurement period or in the six months prior to the measurement period
- M1314 Bmi not documented and no reason is given
- M1315 Colorectal cancer screening results were not documented and reviewed; reason not otherwise specified
- M1316 Current tobacco non-user
- M1317 Patients who are counseled on connection with a csp and explicitly opt out
- M1318 Patients who did not have documented contact with a csp for at least one of their screened positive hrsns within 60 days after screening or documentation that there was no contact with a csp
- M1319 Patients who had documented contact with a csp for at least one of their screened positive hrsns within 60 days after screening